<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">339325</id>
  <title nil="true"/>
  <common-name>3-hydroxy-n,n-bis(2-hydroxyethyl)-4-[(5-methyl-3-oxo-2-phenyl-1h-pyrazol-4-yl)diazenyl]naphthalene-1-sulfonamide</common-name>
  <description>3-hydroxy-n,n-bis(2-hydroxyethyl)-4-[(5-methyl-3-oxo-2-phenyl-1h-pyrazol-4-yl)diazenyl]naphthalene-1-sulfonamide is a chemical compound with the formula C24H25N5O6S. With an average molecular weight of 511.60 g/mol, 3-hydroxy-n,n-bis(2-hydroxyethyl)-4-[(5-methyl-3-oxo-2-phenyl-1h-pyrazol-4-yl)diazenyl]naphthalene-1-sulfonamide is a heavy molecule.</description>
  <cas nil="true"/>
  <pubchem-id>111711</pubchem-id>
  <chemical-formula>C24H25N5O6S</chemical-formula>
  <weight>511.6</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-30T22:36:56Z</created-at>
  <updated-at type="dateTime">2026-08-30T22:36:56Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC1=C(C(=O)N(N1)C2=CC=CC=C2)N=NC3=C(C=C(C4=CC=CC=C43)S(=O)(=O)N(CCO)CCO)O</moldb-smiles>
  <moldb-formula>C24H25N5O6S</moldb-formula>
  <moldb-inchi>InChI=1S/C24H25N5O6S/c1-16-22(24(33)29(27-16)17-7-3-2-4-8-17)25-26-23-19-10-6-5-9-18(19)21(15-20(23)32)36(34,35)28(11-13-30)12-14-31/h2-10,15,27,30-32H,11-14H2,1H3</moldb-inchi>
  <moldb-inchikey>NQBOYKQSIWGRHY-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">511.1525547</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>2.5</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM335218</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>3-hydroxy-n,n-bis(2-hydroxyethyl)-4-[(5-methyl-3-oxo-2-phenyl-1h-pyrazol-4-yl)diazenyl]naphthalene-1-sulfonamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Benzenoids</superklass>
  <klass>Naphthalenes</klass>
  <subklass>Naphthalene sulfonic acids and derivatives</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0289746</sync-id>
  <structure-inchikey>NQBOYKQSIWGRHY-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>8000000000000800000000000000000000000000048000002000000000800000000000020000000060000000004800000000000000000004000000080000000000000000000000000002000000020000000000800000004000000000000000000010100000000000000104040000000001100000000000100000000000000004040000000800000200000000000000000000100000200000000000000000000000000822000040000080000400800000000000000080000110000010000000000040000002100000000000000400000000000042000000200000000020000000040000800000040000000000000000001000000000000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAkAAAAJwAAAIABBgBgAAAAAQMGQCgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:39:51Z</structure-indexed-at>
</compound>
